Tuesday, July 5, 2016
Jury Awards $70M in Johnson & Johnson Risperdal Lawsuit
A Philadelphia jury awarded $70 million to a boy who developed breasts after using antipsychotic drug Risperdal. The drug is manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals, and the jury found that the companies failed to adequately warn doctors and consumers about the risk of gynecomastia in male patients.......
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment